SYNTH MR Stock Swiss Exchange
Equities
SE0005454865
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
|
07-09 | SyntheticMR AB Provides Sales Guidance for the Second Quarter of 2024 | CI |
05-22 | SyntheticMR AB Announces Board Changes | CI |
Sales 2024 * | 76.22M 7.22M 9.89M | Sales 2025 * | 99.19M 9.4M 12.87M | Capitalization | 1.15B 109M 150M |
---|---|---|---|---|---|
Net income 2024 * | 4M 379K 519K | Net income 2025 * | 14M 1.33M 1.82M | EV / Sales 2024 * | 15.1 x |
Net cash position 2024 * | 6.82M 646K 885K | Net cash position 2025 * | 6.81M 645K 884K | EV / Sales 2025 * | 11.6 x |
P/E ratio 2024 * |
277
x | P/E ratio 2025 * |
82.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
0.54% | Free-Float | 42.6% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Harrysson
CEO | Chief Executive Officer | 55 | 19-08-31 |
Founder | 51 | 07-02-15 | |
Johanna Norén
DFI | Director of Finance/CFO | 50 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 12-12-31 | |
Director/Board Member | 60 | 20-12-31 | |
Founder | 51 | 07-02-15 |
1st Jan change | Capi. | |
---|---|---|
-5.52% | 30.25B | |
+40.35% | 9.47B | |
+31.81% | 4.33B | |
-36.54% | 2.49B | |
-6.05% | 1.66B | |
-24.44% | 1.27B | |
-42.92% | 972M | |
-3.82% | 885M | |
-50.69% | 687M |